Search results
Precigen to Host a Webcast on June 3rd to Detail Pivotal Study Results of PRGN-2012 in Recurrent...
FOX21 Colorado Springs· 4 days ago(Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced that the ...
Purple Biotech (NASDAQ:PPBT) Receives Buy Rating from HC Wainwright
ETF DAILY NEWS· 4 days agoPurple Biotech (NASDAQ:PPBT – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a note issued to investors on Tuesday, Benzinga reports. They presently ...
Dr. Reddy's (RDY), Alvotech Unite for Prolia & Xgeva Biosimilar
Zacks via Yahoo Finance· 5 days agoDr. Reddy's (RDY) announces entering into a license and supply agreement with Alvotech to develop...
Rutgers Cancer Institute and RWJBarnabas Health Set to Unveil Extensive, New Cancer Research...
Benzinga· 4 days ago49 scheduled presentations will explore several types of cancer, as well as the next frontier of health equity NEW BRUNSWICK, N.J., May 23, 2024 /PRNewswire/ -- Clinicians and scientists from Rutgers Cancer Institute and
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoPreliminary data from CLN-619 in combination with checkpoint inhibitor pembrolizumab show objective responses in patients with tumor types that are typically unresponsive to pembrolizumab, such ...